Evidence map›Paper›PMID 30200639›Full record

ReviewJournal of fungi (Basel, Switzerland)2018

Standardization of

Olivia L Champion, Richard W Titball, Steven Bates

Abstract readReview
In one paragraph

Review in Journal of fungi (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Distinct Phenotype and Secondary Metabolite Profile Mark a DominantJournal of fungi (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Journal of medical microbiology · 2026
    Review
  7. Carvacrol exhibits potent anti-Frontiers in pharmacology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Microbiology spectrum · 2025
    Article
  12. Article
  13. Article
  14. Journal of fungi (Basel, Switzerland) · 2025
    Article
  15. Nanomaterials (Basel, Switzerland) · 2025
    Review
  16. Article
  17. Evaluation ofMicrobial genomics · 2024
    Article
  18. Article
  19. Article
  20. Pathogens (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olivia L ChampionBiosystems Technology Ltd., 1 Colleton Crescent, Exeter EX2 4DG, UK. o.champion@biosystemstechnology.com.
Richard W TitballCollege of Life and Environmental Science, University of Exeter, Stocker Road, Exeter EX4 4QD, UK. r.w.titball@exeter.ac.uk.ORCID 0000-0002-0162-2077
Steven BatesCollege of Life and Environmental Science, University of Exeter, Stocker Road, Exeter EX4 4QD, UK. s.bates@exeter.ac.uk.ORCID 0000-0003-0489-5705

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade,

Indexed as

end pointfungiGalleria mellonellagenomeinfection modelpathological score

Identifiers

PMID30200639
PMCPMC6162639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.